Treatment of pulmonary embolism by subcutaneous low-molecular-weight heparin in a hemodialysis patient.
Low-molecular-weight heparin (LMWH) has been used in the prophylaxis and treatment of deep vein thrombosis. Data regarding the efficacy of this drug without subsequent use of oral anticoagulant in the treatment of pulmonary embolism is limited. Pulmonary embolism may complicate the use of central venous catheter in hemodialysis. We report a case of acute submassive pulmonary embolism complicating a central venous hemodialysis catheter in a dialysis patient. After the catheter was removed, the patient was treated successfully with subcutaneous injection of LMWH for three months. We conclude that LMWH is safe and effective for treatment of pulmonary embolism in patient on hemodialysis.
Szeto
C C
CC
Department of Medicine, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin.
Wang
A Y
AY
Lui
S F
SF
Lai
K N
KN
Yu
A W
AW
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D006801:Humans; D007601:Jugular Veins; D008297:Male; D017762:Nadroparin / Q000627:therapeutic use*; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000209:etiology; D006435:Renal Dialysis / Q000295:instrumentation
D000925:Anticoagulants; D017762:Nadroparin